CLINICAL_TRIALS
trial_result
· 2022-06-02
Clinical Trial Update: CAP-Ketamine for Antidepressant Resistant PTSD [Phase 2]
Summary
Phase 2 trial update for CAP-Ketamine in antidepressant-resistant PTSD; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: PTSD, Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2022-06-02